Cornerstone Planning Group LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1822587 FAIRFIELD, NJ

Position in ALNY

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$33,087

-$4,689 QoQ

Shares Held

100

+5.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cornerstone Planning Group LLC holds $285,266 across 38 Biotechnology names. ALNY ranks #2 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	116	$51,798
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	100	$33,087
3	REGN	Regeneron Pharmaceuticals, Inc.	35	$27,042
4	RPRX	Royalty Pharma plc	402	$19,283
5	RVMD	Revolution Medicines, Inc.	194	$18,866
6	HALO	Halozyme Therapeutics, Inc.	287	$18,548
7	CRSP	CRISPR Therapeutics AG	300	$14,271
8	ARGX	Argenx SE	15	$10,953

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$33,087	100	+5.3%	Shares	Sole	2026-05-06
2025-12-31	$37,776	95	-80.7%	Shares	Sole	2026-02-02
2025-09-30	$224,352	492	+1071.4%	Shares	Sole	2025-11-04
2025-06-30	$13,695	42	+23.5%	Shares	Sole	2025-08-11
2025-03-31	$9,180	34	+47.8%	Shares	Sole	2025-04-30
2024-12-31	$5,412	23	0.0%	Shares	Sole	2025-01-29
2024-09-30	$6,325	23	+76.9%	Shares	Sole	2024-11-05
2024-06-30	$3,159	13	+1200.0%	Shares	Sole	2024-08-13
2023-12-31	$191	1	0.0%	Shares	Sole	2024-02-12
2023-09-30	$177	1	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.